Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2002 Jun;110(6):A325–A332. doi: 10.1289/ehp.021100325

Infant exposure to dioxin-like compounds in breast milk.

Matthew Lorber 1, Linda Phillips 1
PMCID: PMC1240886  PMID: 12055063

Abstract

We used a one-compartment, first-order pharmacokinetic model to predict the infant body burden of dioxin-like compounds that results from breast-feeding. Validation testing of the model showed a good match between predictions and measurements of dioxin toxic equivalents (TEQs) in breast-fed infants, and the exercise highlighted the importance of the assumption of the rate of dissipation of TEQs in the infant. We evaluated five nursing scenarios: no nursing (i.e., formula only), and nursing for 6 weeks, 6 months, 1 year, and 2 years. We assumed that an infant weighs 3.3 kg at birth and is exposed to a total of 800 pg TEQ/day by consumption of breast milk, leading to an estimated body weight-based dose of 242 pg TEQ/kg-day, which drops to 18 pg TEQ/kg-day after 1 year. This decline is due to declines in dioxin concentration in mother's milk and infant body weight increases. This range is significantly higher, on a body-weight basis, than adult TEQ exposure, which has been estimated to average about 1 pg TEQ/kg-day. For the nursing scenarios of >or= 6 months, we predict that body burdens (expressed as a body lipid concentration) peak at around 9 weeks at 44 ppt TEQ lipid. We predict that the body burden of the formula-fed infants will remain below 10 ppt TEQ lipid during the first year. These results compare to the current adult average body burden of 25 ppt TEQ lipid. We also found that an infant who had been breast-fed for 1 year had an accumulated dose 6 times higher than a 1-year-old infant who had not been breast-fed. For a 70-year lifetime, individuals who had been breast-fed had an accumulated dose 3-18% higher than individuals who had not been breast-fed.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham K., Päpke O., Gross A., Kordonouri O., Wiegand S., Wahn U., Helge H. Time course of PCDD/PCDF/PCB concentrations in breast-feeding mothers and their infants. Chemosphere. 1998 Oct-Nov;37(9-12):1731–1741. doi: 10.1016/s0045-6535(98)00238-0. [DOI] [PubMed] [Google Scholar]
  2. Anderson H. A., Falk C., Hanrahan L., Olson J., Burse V. W., Needham L., Paschal D., Patterson D., Jr, Hill R. H., Jr Profiles of Great Lakes critical pollutants: a sentinel analysis of human blood and urine. The Great Lakes Consortium. Environ Health Perspect. 1998 May;106(5):279–289. doi: 10.1289/ehp.98106279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Birnbaum L. S., Couture L. A. Disposition of octachlorodibenzo-p-dioxin (OCDD) in male rats. Toxicol Appl Pharmacol. 1988 Mar 30;93(1):22–30. doi: 10.1016/0041-008x(88)90022-1. [DOI] [PubMed] [Google Scholar]
  4. Campbell C. A., Teschke K., Bert J., Quintana P. J., Hertzman C. Pharmacokinetic model of dioxin and furan levels in adipose tissue from sawmill work involving chlorophenate fungicides. Chemosphere. 1996 Dec;33(12):2373–2381. doi: 10.1016/s0045-6535(96)00341-4. [DOI] [PubMed] [Google Scholar]
  5. Carrier G., Brunet R. C., Brodeur J. Modeling of the toxicokinetics of polychlorinated dibenzo-p-dioxins and dibenzofurans in mammalians, including humans. I. Nonlinear distribution of PCDD/PCDF body burden between liver and adipose tissues. Toxicol Appl Pharmacol. 1995 Apr;131(2):253–266. doi: 10.1006/taap.1995.1068. [DOI] [PubMed] [Google Scholar]
  6. Carrier G., Brunet R. C., Brodeur J. Modeling of the toxicokinetics of polychlorinated dibenzo-p-dioxins and dibenzofurans in mammalians, including humans. II. Kinetics of absorption and disposition of PCDDs/PCDFs. Toxicol Appl Pharmacol. 1995 Apr;131(2):267–276. doi: 10.1006/taap.1995.1069. [DOI] [PubMed] [Google Scholar]
  7. Falk C., Hanrahan L., Anderson H. A., Kanarek M. S., Draheim L., Needham L., Patterson D., Jr Body burden levels of dioxin, furans, and PCBs among frequent consumers of Great Lakes sport fish. The Great Lakes Consortium. Environ Res. 1999 Feb;80(2 Pt 2):S19–S25. doi: 10.1006/enrs.1998.3906. [DOI] [PubMed] [Google Scholar]
  8. Flesch-Janys D., Becher H., Gurn P., Jung D., Konietzko J., Manz A., Päpke O. Elimination of polychlorinated dibenzo-p-dioxins and dibenzofurans in occupationally exposed persons. J Toxicol Environ Health. 1996 Mar;47(4):363–378. doi: 10.1080/009841096161708. [DOI] [PubMed] [Google Scholar]
  9. Harrison N., Wearne S., Gem M. G., Gleadle A., Startin J., Thorpe S., Wright C., Kelly M., Robinson C., White S. Time trends in human dietary exposure to PCDDs, PCDFs and PCBs in the UK. Chemosphere. 1998 Oct-Nov;37(9-12):1657–1670. doi: 10.1016/s0045-6535(98)00232-x. [DOI] [PubMed] [Google Scholar]
  10. Kreuzer P. E., Csanády G. A., Baur C., Kessler W., Päpke O., Greim H., Filser J. G. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and congeners in infants. A toxicokinetic model of human lifetime body burden by TCDD with special emphasis on its uptake by nutrition. Arch Toxicol. 1997;71(6):383–400. doi: 10.1007/s002040050402. [DOI] [PubMed] [Google Scholar]
  11. LaKind J. S., Berlin C. M., Park C. N., Naiman D. Q., Gudka N. J. Methodology for characterizing distributions of incremental body burdens of 2,3,7,8-TCDD and DDE from breast milk in North American nursing infants. J Toxicol Environ Health A. 2000 Apr 28;59(8):605–639. doi: 10.1080/009841000156628. [DOI] [PubMed] [Google Scholar]
  12. Michalek J. E., Pirkle J. L., Caudill S. P., Tripathi R. C., Patterson D. G., Jr, Needham L. L. Pharmacokinetics of TCDD in veterans of Operation Ranch Hand: 10-year follow-up. J Toxicol Environ Health. 1996 Feb 23;47(3):209–220. doi: 10.1080/009841096161744. [DOI] [PubMed] [Google Scholar]
  13. Patandin S., Dagnelie P. C., Mulder P. G., Op de Coul E., van der Veen J. E., Weisglas-Kuperus N., Sauer P. J. Dietary exposure to polychlorinated biphenyls and dioxins from infancy until adulthood: A comparison between breast-feeding, toddler, and long-term exposure. Environ Health Perspect. 1999 Jan;107(1):45–51. doi: 10.1289/ehp.9910745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Patandin S., Weisglas-Kuperus N., de Ridder M. A., Koopman-Esseboom C., van Staveren W. A., van der Paauw C. G., Sauer P. J. Plasma polychlorinated biphenyl levels in Dutch preschool children either breast-fed or formula-fed during infancy. Am J Public Health. 1997 Oct;87(10):1711–1714. doi: 10.2105/ajph.87.10.1711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pinsky P. F., Lorber M. N. A model to evaluate past exposure to 2,3,7,8-TCDD. J Expo Anal Environ Epidemiol. 1998 Apr-Jun;8(2):187–206. [PubMed] [Google Scholar]
  16. Smith A. H. Infant exposure assessment for breast milk dioxins and furans derived from waste incineration emissions. Risk Anal. 1987 Sep;7(3):347–353. doi: 10.1111/j.1539-6924.1987.tb00470.x. [DOI] [PubMed] [Google Scholar]
  17. Van den Berg M., Birnbaum L., Bosveld A. T., Brunström B., Cook P., Feeley M., Giesy J. P., Hanberg A., Hasegawa R., Kennedy S. W. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ Health Perspect. 1998 Dec;106(12):775–792. doi: 10.1289/ehp.98106775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Van der Molen G. W., Kooijman B. A., Wittsiepe J., Schrey P., Flesch-Janys D., Slob W. Estimation of dioxin and furan elimination rates with a pharmacokinetic model. J Expo Anal Environ Epidemiol. 2000 Nov-Dec;10(6 Pt 1):579–585. doi: 10.1038/sj.jea.7500140. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES